Live: Will Oklo Smash Q1 Earnings Tonight?

Oklo’s last earnings report largely removed financing concerns around the business. The company exited 2025 with roughly $1.4 billion in cash and marketable securities, then added another $1.18 billion through its ATM program in January. Total liquidity now sits near $2.5 billion, versus expected 2026 cash burn of just $80 million to $100 million.

Regulatory progress also accelerated in March, with DOE approval for the Aurora-INL Nuclear Safety Design Agreement and an NRC materials license for Oklo’s Atomic Alchemy subsidiary. Management expects Atomic Alchemy to generate its first revenue in 2026.

Oklo continues standing out in the SMR (small modular reactors) space because of its business model.

Most SMR companies sell reactors to customers, while Oklo plans to own and operate reactors itself and sell electricity directly through long-term agreements. That gives Oklo exposure to recurring power revenue instead of one-time equipment sales.

The global SMR offtake pipeline has climbed to roughly 45 GW as hyperscalers race to secure future AI power capacity. Oklo is also using the DOE Reactor Pilot Program for parts of its licensing process, which could help accelerate deployment timelines relative to peers.

Oklo’s Q4 earnings tonight could become a major catalyst for the stock.

Shares trade near $74, down roughly 50% from the stock’s October 2025 high near $174, despite continued progress across commercial agreements and nuclear demand trends. Meta signed a 1.2 GW power agreement with Oklo in January, while EPRI now projects data centers could consume 9-17% of U.S. electricity by 2030.

The market’s hesitation comes down to timing, with Oklo not expected to deliver its first power until 2027. Investors will now look for updates on Aurora-INL, the July 2026 criticality target, and the long-rumored OpenAI partnership.

Oklo (NYSE:OKLO | OKLO Price Prediction) reports at 4 PM ET after the bell tonight.

Top 5 Analyst Questions

• Is the 14 GW pipeline converting from non-binding LOIs into binding PPAs?
• Timing of the NRC combined license application (COLA) submission?
• Did Atomic Alchemy generate any 2026 radioisotope revenue?
• Cash burn trajectory versus the prior $275.30M liquidity position?
• Updates on HALEU sourcing and the Lightbridge recycling collaboration?

Key Topics

• Idaho National Laboratory site readiness for late 2027 deployment
• Equinix 500 MW LOI and Switch 12 GW agreement progression
• Aurora powerhouse scaling to 75 MW

Red Flags

• Slippage in COLA timing or first deployment past early 2028
• Equity raise signaling or accelerating burn
• Customer attrition from the 2,100 MW-to-14 GW pipeline

Analysts’ average price target sits at $91.36, with shares down 5.93% today to $73.83.

This Quarter Could Reset the Narrative

Oklo shares are up 178% over the past year as investors increasingly price in a credible path toward commercial advanced nuclear deployment. The company now has NRC Principal Design Criteria approval in hand, a growing customer pipeline, and strategic relationships tied to rising AI-driven power demand.

This quarter matters because the focus shifts from regulatory progress toward commercial execution.

Investors want to see whether Atomic Alchemy begins contributing early radioisotope revenue, whether the Aurora licensing timeline continues to support targeted 2027 to 2028 deployment, and whether operating cash burn remains controlled as development activity ramps up.

If management delivers measurable progress across commercialization, licensing, and deployment readiness, Oklo’s long-term thesis will strengthen materially.